A protein tertiary structure mimetic modulator of the Hippo signalling pathway

被引:40
|
作者
Adihou, Helene [1 ,2 ]
Gopalakrishnan, Ranganath [1 ,2 ]
Foerster, Tim [2 ]
Gueret, Stephanie M. [1 ,2 ]
Gasper, Raphael [3 ]
Geschwindner, Stefan [4 ]
Garcia, Carmen Carrillo [5 ]
Karatas, Hacer [3 ]
Pobbati, Ajaybabu, V [6 ]
Vazquez-Chantada, Mercedes [7 ]
Davey, Paul [8 ]
Wassvik, Carola M. [1 ]
Pang, Jeremy Kah Sheng [9 ,10 ]
Soh, Boon Seng [9 ,10 ,11 ]
Hong, Wanjin [6 ]
Chiarparin, Elisabetta [8 ]
Schade, Dennis [5 ]
Plowright, Alleyn T. [1 ]
Valeur, Eric [1 ]
Lemurell, Malin [1 ]
Grossmann, Tom N. [12 ,13 ]
Waldmann, Herbert [3 ,14 ]
机构
[1] AstraZeneca, Med Chem Res & Early Dev Cardiovasc, Renal & Metab, BioPharmaceut R&D, Gothenburg, Sweden
[2] AstraZeneca MPI Satellite Unit, Dortmund, Germany
[3] Max Planck Inst Mol Physiol, Dortmund, Germany
[4] AstraZeneca, Struct & Biophys, Discovery Sci, R&D, Gothenburg, Sweden
[5] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Kiel, Germany
[6] ASTAR, Dept Multimodal Mol M3 Biol, Inst Mol & Cell Biol, Singapore, Singapore
[7] AstraZeneca, BioPharmaceut R&D, Mechanist Biol & Profiling, Cambridge, England
[8] AstraZeneca, Oncol R&D, Med Chem, Cambridge, England
[9] ASTAR, Dis Modelling & Therapeut Lab, Inst Mol & Cell Biol, Singapore, Singapore
[10] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore
[11] Guangzhou Med Univ, Key Lab Major Obstetr Dis Guangdong Prov, Affiliated Hosp 3, Guangzhou, Peoples R China
[12] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands
[13] Vrije Univ Amsterdam, Amsterdam Inst Mol & Life Sci AIMMS, Amsterdam, Netherlands
[14] Tech Univ Dortmund, Dept Chem & Chem Biol, Dortmund, Germany
基金
欧洲研究理事会;
关键词
CARDIOMYOCYTE PROLIFERATION; TRANSCRIPTION FACTORS; INHIBITOR; REGENERATION; ACTIVATION; THERAPY; TARGETS; DOMAIN;
D O I
10.1038/s41467-020-19224-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Transcription factors are key protein effectors in the regulation of gene transcription, and in many cases their activity is regulated via a complex network of protein-protein interactions (PPI). The chemical modulation of transcription factor activity is a long-standing goal in drug discovery but hampered by the difficulties associated with the targeting of PPIs, in particular when extended and flat protein interfaces are involved. Peptidomimetics have been applied to inhibit PPIs, however with variable success, as for certain interfaces the mimicry of a single secondary structure element is insufficient to obtain high binding affinities. Here, we describe the design and characterization of a stabilized protein tertiary structure that acts as an inhibitor of the interaction between the transcription factor TEAD and its co-repressor VGL4, both playing a central role in the Hippo signalling pathway. Modification of the inhibitor with a cell-penetrating entity yielded a cell-permeable proteomimetic that activates cell proliferation via regulation of the Hippo pathway, highlighting the potential of protein tertiary structure mimetics as an emerging class of PPI modulators. Targeting the interaction between transcription factor TEAD and its co-repressor VGL4 is an attractive strategy to chemically modulate Hippo signaling. Here, the authors develop a proteomimetic with stabilized tertiary structure that inhibits the TEAD:VGL4 interaction in vitro and in cells.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] A protein tertiary structure mimetic modulator of the Hippo signalling pathway
    Hélène Adihou
    Ranganath Gopalakrishnan
    Tim Förster
    Stéphanie M. Guéret
    Raphael Gasper
    Stefan Geschwindner
    Carmen Carrillo García
    Hacer Karatas
    Ajaybabu V. Pobbati
    Mercedes Vazquez‐Chantada
    Paul Davey
    Carola M. Wassvik
    Jeremy Kah Sheng Pang
    Boon Seng Soh
    Wanjin Hong
    Elisabetta Chiarparin
    Dennis Schade
    Alleyn T. Plowright
    Eric Valeur
    Malin Lemurell
    Tom N. Grossmann
    Herbert Waldmann
    [J]. Nature Communications, 11
  • [2] The Hippo in the room: Targeting the Hippo signalling pathway for osteosarcoma therapies
    Rothzerg, Emel
    Ingley, Evan
    Mullin, Benjamin
    Xue, Wei
    Wood, David
    Xu, Jiake
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (03) : 1606 - 1615
  • [3] Targeting the Hippo signalling pathway for cancer treatment
    Nakatani, Keisuke
    Maehama, Tomohiko
    Nishio, Miki
    Goto, Hiroki
    Kato, Wakako
    Omori, Hirofumi
    Miyachi, Yosuke
    Togashi, Hideru
    Shimono, Yohei
    Suzuki, Akira
    [J]. JOURNAL OF BIOCHEMISTRY, 2017, 161 (03): : 237 - 244
  • [4] The Spectrin cytoskeleton regulates the Hippo signalling pathway
    Fletcher, Georgina C.
    Elbediwy, Ahmed
    Khanal, Ichha
    Ribeiro, Paulo S.
    Tapon, Nic
    Thompson, Barry J.
    [J]. EMBO JOURNAL, 2015, 34 (07): : 940 - 954
  • [5] CELL SIGNALLING A new Hippo pathway component
    Du Toit, Andrea
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (04) : 196 - 196
  • [6] New Therapeutic Approach for Targeting Hippo Signalling Pathway
    Leticia Dominguez-Berrocal
    Erica Cirri
    Xiguang Zhang
    Laura Andrini
    Gustavo H. Marin
    Sophie Lebel-Binay
    Angelita Rebollo
    [J]. Scientific Reports, 9
  • [7] New Therapeutic Approach for Targeting Hippo Signalling Pathway
    Dominguez-Berrocal, Leticia
    Cirri, Erica
    Zhang, Xiguang
    Andrini, Laura
    Marin, Gustavo H.
    Lebel-Binay, Sophie
    Rebollo, Angelita
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [8] Emerging role of Hippo signalling pathway in bladder cancer
    Xia, Jianling
    Zeng, Ming
    Zhu, Hua
    Chen, Xiangjian
    Weng, Zhiliang
    Li, Shi
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (01) : 4 - 15
  • [9] The Hippo signalling pathway and its impact on eye diseases
    Du, Yuxiang
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (08)
  • [10] The Roles of NDR Protein Kinases in Hippo Signalling
    Hergovich, Alexander
    [J]. GENES, 2016, 7 (05):